BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200728T100000
DTEND;TZID=America/Vancouver:20200728T110000
DTSTAMP:20260404T214224
CREATED:20200714T170013Z
LAST-MODIFIED:20200714T170013Z
UID:12049-1595930400-1595934000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Bernard Thébaud
DESCRIPTION:In this episode of Stem Cells from the Sofa\, Dr Bernard Thébaud\, Senior Scientist at the Ottawa Hospital Research Institute & CHEO Research Institute and Neonatologist at The Ottawa Hospital & Children’s Hospital of Eastern Ontario\, discusses the journey his group has undertaken in developing a cell therapy for improving the outcome of preterm infants with lung disease. \nDr. Thébaud’s talk is entitled\, “How the “INCuBAToR” gave birth to “HULC-I”\, a phase I trial of cord-derived mesenchymal stromal cells for neonatal lung disease” \nIntended audience: scientists\, trainees and research professionals.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-bernard-thebaud/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200728T100000
DTEND;TZID=America/Vancouver:20200728T110000
DTSTAMP:20260404T214224
CREATED:20200714T170013Z
LAST-MODIFIED:20200714T170013Z
UID:26215-1595930400-1595934000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Bernard Thébaud
DESCRIPTION:In this episode of Stem Cells from the Sofa\, Dr Bernard Thébaud\, Senior Scientist at the Ottawa Hospital Research Institute & CHEO Research Institute and Neonatologist at The Ottawa Hospital & Children’s Hospital of Eastern Ontario\, discusses the journey his group has undertaken in developing a cell therapy for improving the outcome of preterm infants with lung disease. \nDr. Thébaud’s talk is entitled\, “How the “INCuBAToR” gave birth to “HULC-I”\, a phase I trial of cord-derived mesenchymal stromal cells for neonatal lung disease” \nIntended audience: scientists\, trainees and research professionals.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-bernard-thebaud-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200728T100000
DTEND;TZID=America/Vancouver:20200728T110000
DTSTAMP:20260404T214224
CREATED:20200714T170013Z
LAST-MODIFIED:20200714T170013Z
UID:27830-1595930400-1595934000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Bernard Thébaud
DESCRIPTION:In this episode of Stem Cells from the Sofa\, Dr Bernard Thébaud\, Senior Scientist at the Ottawa Hospital Research Institute & CHEO Research Institute and Neonatologist at The Ottawa Hospital & Children’s Hospital of Eastern Ontario\, discusses the journey his group has undertaken in developing a cell therapy for improving the outcome of preterm infants with lung disease. \nDr. Thébaud’s talk is entitled\, “How the “INCuBAToR” gave birth to “HULC-I”\, a phase I trial of cord-derived mesenchymal stromal cells for neonatal lung disease” \nIntended audience: scientists\, trainees and research professionals.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-bernard-thebaud-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200728T100000
DTEND;TZID=America/Vancouver:20200728T110000
DTSTAMP:20260404T214224
CREATED:20200714T170013Z
LAST-MODIFIED:20200714T170013Z
UID:30913-1595930400-1595934000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Bernard Thébaud
DESCRIPTION:In this episode of Stem Cells from the Sofa\, Dr Bernard Thébaud\, Senior Scientist at the Ottawa Hospital Research Institute & CHEO Research Institute and Neonatologist at The Ottawa Hospital & Children’s Hospital of Eastern Ontario\, discusses the journey his group has undertaken in developing a cell therapy for improving the outcome of preterm infants with lung disease. \nDr. Thébaud’s talk is entitled\, “How the “INCuBAToR” gave birth to “HULC-I”\, a phase I trial of cord-derived mesenchymal stromal cells for neonatal lung disease” \nIntended audience: scientists\, trainees and research professionals.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-bernard-thebaud-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200728T100000
DTEND;TZID=America/Vancouver:20200728T110000
DTSTAMP:20260404T214224
CREATED:20200714T170013Z
LAST-MODIFIED:20200714T170013Z
UID:32373-1595930400-1595934000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Bernard Thébaud
DESCRIPTION:In this episode of Stem Cells from the Sofa\, Dr Bernard Thébaud\, Senior Scientist at the Ottawa Hospital Research Institute & CHEO Research Institute and Neonatologist at The Ottawa Hospital & Children’s Hospital of Eastern Ontario\, discusses the journey his group has undertaken in developing a cell therapy for improving the outcome of preterm infants with lung disease. \nDr. Thébaud’s talk is entitled\, “How the “INCuBAToR” gave birth to “HULC-I”\, a phase I trial of cord-derived mesenchymal stromal cells for neonatal lung disease” \nIntended audience: scientists\, trainees and research professionals.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-bernard-thebaud-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T090000
DTEND;TZID=America/Vancouver:20200729T100000
DTSTAMP:20260404T214224
CREATED:20200716T174629Z
LAST-MODIFIED:20200716T174629Z
UID:12063-1596013200-1596016800@scienceinvancouver.com
SUMMARY:Live Panel: Advancing Tissue Therapeutics to the Clinic
DESCRIPTION:Join our panel discussion on biomaterial sourcing\, cell manufacturing\, and regulatory strategies to develop tissue therapeutics.\n\nPANELISTS
URL:https://scienceinvancouver.com/event/live-panel-advancing-tissue-therapeutics-to-the-clinic/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T090000
DTEND;TZID=America/Vancouver:20200729T100000
DTSTAMP:20260404T214224
CREATED:20200716T174629Z
LAST-MODIFIED:20200716T174629Z
UID:26216-1596013200-1596016800@scienceinvancouver.com
SUMMARY:Live Panel: Advancing Tissue Therapeutics to the Clinic
DESCRIPTION:Join our panel discussion on biomaterial sourcing\, cell manufacturing\, and regulatory strategies to develop tissue therapeutics.\n\nPANELISTS
URL:https://scienceinvancouver.com/event/live-panel-advancing-tissue-therapeutics-to-the-clinic-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T090000
DTEND;TZID=America/Vancouver:20200729T100000
DTSTAMP:20260404T214224
CREATED:20200716T174629Z
LAST-MODIFIED:20200716T174629Z
UID:27831-1596013200-1596016800@scienceinvancouver.com
SUMMARY:Live Panel: Advancing Tissue Therapeutics to the Clinic
DESCRIPTION:Join our panel discussion on biomaterial sourcing\, cell manufacturing\, and regulatory strategies to develop tissue therapeutics.\n\nPANELISTS
URL:https://scienceinvancouver.com/event/live-panel-advancing-tissue-therapeutics-to-the-clinic-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T090000
DTEND;TZID=America/Vancouver:20200729T100000
DTSTAMP:20260404T214224
CREATED:20200716T174629Z
LAST-MODIFIED:20200716T174629Z
UID:30914-1596013200-1596016800@scienceinvancouver.com
SUMMARY:Live Panel: Advancing Tissue Therapeutics to the Clinic
DESCRIPTION:Join our panel discussion on biomaterial sourcing\, cell manufacturing\, and regulatory strategies to develop tissue therapeutics.\n\nPANELISTS
URL:https://scienceinvancouver.com/event/live-panel-advancing-tissue-therapeutics-to-the-clinic-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T090000
DTEND;TZID=America/Vancouver:20200729T100000
DTSTAMP:20260404T214224
CREATED:20200716T174629Z
LAST-MODIFIED:20200716T174629Z
UID:32374-1596013200-1596016800@scienceinvancouver.com
SUMMARY:Live Panel: Advancing Tissue Therapeutics to the Clinic
DESCRIPTION:Join our panel discussion on biomaterial sourcing\, cell manufacturing\, and regulatory strategies to develop tissue therapeutics.\n\nPANELISTS
URL:https://scienceinvancouver.com/event/live-panel-advancing-tissue-therapeutics-to-the-clinic-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T140000
DTEND;TZID=America/Vancouver:20200729T160000
DTSTAMP:20260404T214224
CREATED:20200706T162204Z
LAST-MODIFIED:20200706T162204Z
UID:11928-1596031200-1596038400@scienceinvancouver.com
SUMMARY:Women's Health Research Institute Summer Social Media Series
DESCRIPTION:As research teams pivot to our new virtual environment\, social media is becoming an important tool to support the work of the research community. \nThe WHRI is pleased to offer our first Summer Social Media Series\, a 4-part workshop to support your social media needs. The workshop includes lectures\, group discussions\, and breakout sessions. \nTopics include: \n\nSocial Media 101: platforms and practice\nSocial Media Planning: partnerships\, recruitment\, and knowledge translation\nSocial Media Metrics: tips and tools for data collection and visualization\n\nDates + Times: \n\nWednesday July 15\, 2 – 4 pm\nWednesday July 29\, 2 – 4 pm\nWednesday August 12\, 2 – 4 pm\nWednesday August 26\, 2 – 4 pm\n\nRegister now \nIf you are interested in this workshop or have any questions\, please contact whri.communications@cw.bc.ca.
URL:https://scienceinvancouver.com/event/womens-health-research-institute-summer-social-media-series-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/WHRI-social-media-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T140000
DTEND;TZID=America/Vancouver:20200729T160000
DTSTAMP:20260404T214224
CREATED:20200706T162204Z
LAST-MODIFIED:20200706T162204Z
UID:26208-1596031200-1596038400@scienceinvancouver.com
SUMMARY:Women's Health Research Institute Summer Social Media Series
DESCRIPTION:As research teams pivot to our new virtual environment\, social media is becoming an important tool to support the work of the research community. \nThe WHRI is pleased to offer our first Summer Social Media Series\, a 4-part workshop to support your social media needs. The workshop includes lectures\, group discussions\, and breakout sessions. \nTopics include: \n\nSocial Media 101: platforms and practice\nSocial Media Planning: partnerships\, recruitment\, and knowledge translation\nSocial Media Metrics: tips and tools for data collection and visualization\n\nDates + Times: \n\nWednesday July 15\, 2 – 4 pm\nWednesday July 29\, 2 – 4 pm\nWednesday August 12\, 2 – 4 pm\nWednesday August 26\, 2 – 4 pm\n\nRegister now \nIf you are interested in this workshop or have any questions\, please contact whri.communications@cw.bc.ca.
URL:https://scienceinvancouver.com/event/womens-health-research-institute-summer-social-media-series-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/WHRI-social-media-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T140000
DTEND;TZID=America/Vancouver:20200729T160000
DTSTAMP:20260404T214224
CREATED:20200706T162204Z
LAST-MODIFIED:20200706T162204Z
UID:27823-1596031200-1596038400@scienceinvancouver.com
SUMMARY:Women's Health Research Institute Summer Social Media Series
DESCRIPTION:As research teams pivot to our new virtual environment\, social media is becoming an important tool to support the work of the research community. \nThe WHRI is pleased to offer our first Summer Social Media Series\, a 4-part workshop to support your social media needs. The workshop includes lectures\, group discussions\, and breakout sessions. \nTopics include: \n\nSocial Media 101: platforms and practice\nSocial Media Planning: partnerships\, recruitment\, and knowledge translation\nSocial Media Metrics: tips and tools for data collection and visualization\n\nDates + Times: \n\nWednesday July 15\, 2 – 4 pm\nWednesday July 29\, 2 – 4 pm\nWednesday August 12\, 2 – 4 pm\nWednesday August 26\, 2 – 4 pm\n\nRegister now \nIf you are interested in this workshop or have any questions\, please contact whri.communications@cw.bc.ca.
URL:https://scienceinvancouver.com/event/womens-health-research-institute-summer-social-media-series-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/WHRI-social-media-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T140000
DTEND;TZID=America/Vancouver:20200729T160000
DTSTAMP:20260404T214224
CREATED:20200706T162204Z
LAST-MODIFIED:20200706T162204Z
UID:30906-1596031200-1596038400@scienceinvancouver.com
SUMMARY:Women's Health Research Institute Summer Social Media Series
DESCRIPTION:As research teams pivot to our new virtual environment\, social media is becoming an important tool to support the work of the research community. \nThe WHRI is pleased to offer our first Summer Social Media Series\, a 4-part workshop to support your social media needs. The workshop includes lectures\, group discussions\, and breakout sessions. \nTopics include: \n\nSocial Media 101: platforms and practice\nSocial Media Planning: partnerships\, recruitment\, and knowledge translation\nSocial Media Metrics: tips and tools for data collection and visualization\n\nDates + Times: \n\nWednesday July 15\, 2 – 4 pm\nWednesday July 29\, 2 – 4 pm\nWednesday August 12\, 2 – 4 pm\nWednesday August 26\, 2 – 4 pm\n\nRegister now \nIf you are interested in this workshop or have any questions\, please contact whri.communications@cw.bc.ca.
URL:https://scienceinvancouver.com/event/womens-health-research-institute-summer-social-media-series-2-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/WHRI-social-media-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200729T140000
DTEND;TZID=America/Vancouver:20200729T160000
DTSTAMP:20260404T214224
CREATED:20200706T162204Z
LAST-MODIFIED:20200706T162204Z
UID:32366-1596031200-1596038400@scienceinvancouver.com
SUMMARY:Women's Health Research Institute Summer Social Media Series
DESCRIPTION:As research teams pivot to our new virtual environment\, social media is becoming an important tool to support the work of the research community. \nThe WHRI is pleased to offer our first Summer Social Media Series\, a 4-part workshop to support your social media needs. The workshop includes lectures\, group discussions\, and breakout sessions. \nTopics include: \n\nSocial Media 101: platforms and practice\nSocial Media Planning: partnerships\, recruitment\, and knowledge translation\nSocial Media Metrics: tips and tools for data collection and visualization\n\nDates + Times: \n\nWednesday July 15\, 2 – 4 pm\nWednesday July 29\, 2 – 4 pm\nWednesday August 12\, 2 – 4 pm\nWednesday August 26\, 2 – 4 pm\n\nRegister now \nIf you are interested in this workshop or have any questions\, please contact whri.communications@cw.bc.ca.
URL:https://scienceinvancouver.com/event/womens-health-research-institute-summer-social-media-series-2-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/WHRI-social-media-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200805T090000
DTEND;TZID=America/Vancouver:20200805T100000
DTSTAMP:20260404T214224
CREATED:20200723T153616Z
LAST-MODIFIED:20200723T153616Z
UID:12133-1596618000-1596621600@scienceinvancouver.com
SUMMARY:Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System
DESCRIPTION:Infectious Disease Webinar Series\nWith a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic\, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However\, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation\, part of our Infectious Disease Webinar Series\, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection. \nJoin us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session. \n\n\n\n\n\n\nEric Song\, MD/PhD Candidate\nYale University\n\n\n\n\n\n\n\nLive Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5\, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC \n\n\nIf you are unable to attend the live webinar\, please register and you will receive a link for the recording. \n\n\n\n\nEric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors\, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.
URL:https://scienceinvancouver.com/event/webinar-impact-of-sars-cov-2-infection-on-the-central-nervous-system/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/COVID-STEMCELL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200805T090000
DTEND;TZID=America/Vancouver:20200805T100000
DTSTAMP:20260404T214224
CREATED:20200723T153616Z
LAST-MODIFIED:20200723T153616Z
UID:26220-1596618000-1596621600@scienceinvancouver.com
SUMMARY:Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System
DESCRIPTION:Infectious Disease Webinar Series\nWith a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic\, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However\, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation\, part of our Infectious Disease Webinar Series\, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection. \nJoin us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session. \n\n\n\n\n\n\nEric Song\, MD/PhD Candidate\nYale University\n\n\n\n\n\n\n\nLive Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5\, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC \n\n\nIf you are unable to attend the live webinar\, please register and you will receive a link for the recording. \n\n\n\n\nEric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors\, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.
URL:https://scienceinvancouver.com/event/webinar-impact-of-sars-cov-2-infection-on-the-central-nervous-system-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/COVID-STEMCELL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200805T090000
DTEND;TZID=America/Vancouver:20200805T100000
DTSTAMP:20260404T214224
CREATED:20200723T153616Z
LAST-MODIFIED:20200723T153616Z
UID:27835-1596618000-1596621600@scienceinvancouver.com
SUMMARY:Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System
DESCRIPTION:Infectious Disease Webinar Series\nWith a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic\, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However\, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation\, part of our Infectious Disease Webinar Series\, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection. \nJoin us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session. \n\n\n\n\n\n\nEric Song\, MD/PhD Candidate\nYale University\n\n\n\n\n\n\n\nLive Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5\, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC \n\n\nIf you are unable to attend the live webinar\, please register and you will receive a link for the recording. \n\n\n\n\nEric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors\, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.
URL:https://scienceinvancouver.com/event/webinar-impact-of-sars-cov-2-infection-on-the-central-nervous-system-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/COVID-STEMCELL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200805T090000
DTEND;TZID=America/Vancouver:20200805T100000
DTSTAMP:20260404T214224
CREATED:20200723T153616Z
LAST-MODIFIED:20200723T153616Z
UID:30918-1596618000-1596621600@scienceinvancouver.com
SUMMARY:Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System
DESCRIPTION:Infectious Disease Webinar Series\nWith a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic\, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However\, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation\, part of our Infectious Disease Webinar Series\, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection. \nJoin us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session. \n\n\n\n\n\n\nEric Song\, MD/PhD Candidate\nYale University\n\n\n\n\n\n\n\nLive Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5\, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC \n\n\nIf you are unable to attend the live webinar\, please register and you will receive a link for the recording. \n\n\n\n\nEric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors\, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.
URL:https://scienceinvancouver.com/event/webinar-impact-of-sars-cov-2-infection-on-the-central-nervous-system-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/COVID-STEMCELL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200805T090000
DTEND;TZID=America/Vancouver:20200805T100000
DTSTAMP:20260404T214224
CREATED:20200723T153616Z
LAST-MODIFIED:20200723T153616Z
UID:32378-1596618000-1596621600@scienceinvancouver.com
SUMMARY:Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System
DESCRIPTION:Infectious Disease Webinar Series\nWith a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic\, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However\, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation\, part of our Infectious Disease Webinar Series\, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection. \nJoin us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session. \n\n\n\n\n\n\nEric Song\, MD/PhD Candidate\nYale University\n\n\n\n\n\n\n\nLive Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5\, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC \n\n\nIf you are unable to attend the live webinar\, please register and you will receive a link for the recording. \n\n\n\n\nEric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors\, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.
URL:https://scienceinvancouver.com/event/webinar-impact-of-sars-cov-2-infection-on-the-central-nervous-system-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/07/COVID-STEMCELL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200806T080000
DTEND;TZID=America/Vancouver:20200806T170000
DTSTAMP:20260404T214224
CREATED:20200806T153416Z
LAST-MODIFIED:20200806T153416Z
UID:12257-1596700800-1596733200@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:Keynote Speaker Biographies\n\n\n\n\nDr. Bradley E. Bernstein is a Professor of Pathology at Mass General Hospital and Harvard Medical School\, and the Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein’s research focuses on epigenetic gene regulation. His lab studies how gene activity is controlled by noncoding regulatory elements called ‘enhancers’\, and by the way the genes are packaged into chromatin. He is a leader of the NIH’s ENCODE project that is mapping the locations and functions of all noncoding elements in the human genome. His work is notable for the identification of chromatin structures that underlie stem cell pluripotency\, the annotation of enhancers associated with autoimmunity and other diseases\, and the characterization of epigenetic aberrations that turn on oncogenes and drive tumors. \nDr. Bernstein holds the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and is an Elizabeth and Michael Ruane Endowed Scholar in Endocrine Pathology. He received his B.S. from Yale University and his M.D. and Ph.D. from the University of Washington\, before completing a residency in clinical pathology and postdoctoral research at Harvard University. Honors include an Early Career Scientist Award from the Howard Hughes Medical Institute\, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund\, the NIH Director’s Pioneer Award\, an American Cancer Society Professorship and the Paul Marks Prize for Cancer Research. \n\n\n\n\n \n \n\n\n\n\n\n\n\nDr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief Scientific Officer and interim Chief Operating Officer at the Dana-Farber Cancer Institute. \nDr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer and have formed the foundation of new translational studies. Dr. Hahn and his colleagues helped demonstrate that activation of the reverse transcriptase telomerase plays an essential role in malignant transformation. This observation provided the means to create novel experimental model systems to identify and characterize the cooperative genetic interactions that lead to malignant transformation. Together with his colleagues at the Broad Institute\, he helped develop genome scale tools and technology to perform somatic cell genetics in human cells. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools\, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn and his collaborators are now engaged in clinical trials testing whether inhibition both of new oncogenes or synthetic lethal partners identified by these approaches will lead to clinical responses. \nDr. Hahn has served as the President of the American Society for Clinical Investigation and has been elected to the Association of American Physicians. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer (2000)\, a Howard Temin Award from the National Cancer Institute (2001)\, the Ho-Am Prize in Medicine (2010)\, the Richard and Hinda Rosenthal Award from AACR (2015) and the Claire and Richard Morse Award (2019).
URL:https://scienceinvancouver.com/event/bc-cancer-research-day/
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/bccancerreserachday2020_RearchDay2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200806T080000
DTEND;TZID=America/Vancouver:20200806T170000
DTSTAMP:20260404T214224
CREATED:20200806T153416Z
LAST-MODIFIED:20200806T153416Z
UID:26226-1596700800-1596733200@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:Keynote Speaker Biographies\n\n\n\n\nDr. Bradley E. Bernstein is a Professor of Pathology at Mass General Hospital and Harvard Medical School\, and the Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein’s research focuses on epigenetic gene regulation. His lab studies how gene activity is controlled by noncoding regulatory elements called ‘enhancers’\, and by the way the genes are packaged into chromatin. He is a leader of the NIH’s ENCODE project that is mapping the locations and functions of all noncoding elements in the human genome. His work is notable for the identification of chromatin structures that underlie stem cell pluripotency\, the annotation of enhancers associated with autoimmunity and other diseases\, and the characterization of epigenetic aberrations that turn on oncogenes and drive tumors. \nDr. Bernstein holds the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and is an Elizabeth and Michael Ruane Endowed Scholar in Endocrine Pathology. He received his B.S. from Yale University and his M.D. and Ph.D. from the University of Washington\, before completing a residency in clinical pathology and postdoctoral research at Harvard University. Honors include an Early Career Scientist Award from the Howard Hughes Medical Institute\, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund\, the NIH Director’s Pioneer Award\, an American Cancer Society Professorship and the Paul Marks Prize for Cancer Research. \n\n\n\n\n \n \n\n\n\n\n\n\n\nDr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief Scientific Officer and interim Chief Operating Officer at the Dana-Farber Cancer Institute. \nDr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer and have formed the foundation of new translational studies. Dr. Hahn and his colleagues helped demonstrate that activation of the reverse transcriptase telomerase plays an essential role in malignant transformation. This observation provided the means to create novel experimental model systems to identify and characterize the cooperative genetic interactions that lead to malignant transformation. Together with his colleagues at the Broad Institute\, he helped develop genome scale tools and technology to perform somatic cell genetics in human cells. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools\, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn and his collaborators are now engaged in clinical trials testing whether inhibition both of new oncogenes or synthetic lethal partners identified by these approaches will lead to clinical responses. \nDr. Hahn has served as the President of the American Society for Clinical Investigation and has been elected to the Association of American Physicians. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer (2000)\, a Howard Temin Award from the National Cancer Institute (2001)\, the Ho-Am Prize in Medicine (2010)\, the Richard and Hinda Rosenthal Award from AACR (2015) and the Claire and Richard Morse Award (2019).
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-3/
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/bccancerreserachday2020_RearchDay2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200806T080000
DTEND;TZID=America/Vancouver:20200806T170000
DTSTAMP:20260404T214224
CREATED:20200806T153416Z
LAST-MODIFIED:20200806T153416Z
UID:27841-1596700800-1596733200@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:Keynote Speaker Biographies\n\n\n\n\nDr. Bradley E. Bernstein is a Professor of Pathology at Mass General Hospital and Harvard Medical School\, and the Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein’s research focuses on epigenetic gene regulation. His lab studies how gene activity is controlled by noncoding regulatory elements called ‘enhancers’\, and by the way the genes are packaged into chromatin. He is a leader of the NIH’s ENCODE project that is mapping the locations and functions of all noncoding elements in the human genome. His work is notable for the identification of chromatin structures that underlie stem cell pluripotency\, the annotation of enhancers associated with autoimmunity and other diseases\, and the characterization of epigenetic aberrations that turn on oncogenes and drive tumors. \nDr. Bernstein holds the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and is an Elizabeth and Michael Ruane Endowed Scholar in Endocrine Pathology. He received his B.S. from Yale University and his M.D. and Ph.D. from the University of Washington\, before completing a residency in clinical pathology and postdoctoral research at Harvard University. Honors include an Early Career Scientist Award from the Howard Hughes Medical Institute\, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund\, the NIH Director’s Pioneer Award\, an American Cancer Society Professorship and the Paul Marks Prize for Cancer Research. \n\n\n\n\n \n \n\n\n\n\n\n\n\nDr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief Scientific Officer and interim Chief Operating Officer at the Dana-Farber Cancer Institute. \nDr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer and have formed the foundation of new translational studies. Dr. Hahn and his colleagues helped demonstrate that activation of the reverse transcriptase telomerase plays an essential role in malignant transformation. This observation provided the means to create novel experimental model systems to identify and characterize the cooperative genetic interactions that lead to malignant transformation. Together with his colleagues at the Broad Institute\, he helped develop genome scale tools and technology to perform somatic cell genetics in human cells. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools\, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn and his collaborators are now engaged in clinical trials testing whether inhibition both of new oncogenes or synthetic lethal partners identified by these approaches will lead to clinical responses. \nDr. Hahn has served as the President of the American Society for Clinical Investigation and has been elected to the Association of American Physicians. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer (2000)\, a Howard Temin Award from the National Cancer Institute (2001)\, the Ho-Am Prize in Medicine (2010)\, the Richard and Hinda Rosenthal Award from AACR (2015) and the Claire and Richard Morse Award (2019).
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-4/
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/bccancerreserachday2020_RearchDay2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200806T080000
DTEND;TZID=America/Vancouver:20200806T170000
DTSTAMP:20260404T214224
CREATED:20200806T153416Z
LAST-MODIFIED:20200806T153416Z
UID:30924-1596700800-1596733200@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:Keynote Speaker Biographies\n\n\n\n\nDr. Bradley E. Bernstein is a Professor of Pathology at Mass General Hospital and Harvard Medical School\, and the Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein’s research focuses on epigenetic gene regulation. His lab studies how gene activity is controlled by noncoding regulatory elements called ‘enhancers’\, and by the way the genes are packaged into chromatin. He is a leader of the NIH’s ENCODE project that is mapping the locations and functions of all noncoding elements in the human genome. His work is notable for the identification of chromatin structures that underlie stem cell pluripotency\, the annotation of enhancers associated with autoimmunity and other diseases\, and the characterization of epigenetic aberrations that turn on oncogenes and drive tumors. \nDr. Bernstein holds the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and is an Elizabeth and Michael Ruane Endowed Scholar in Endocrine Pathology. He received his B.S. from Yale University and his M.D. and Ph.D. from the University of Washington\, before completing a residency in clinical pathology and postdoctoral research at Harvard University. Honors include an Early Career Scientist Award from the Howard Hughes Medical Institute\, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund\, the NIH Director’s Pioneer Award\, an American Cancer Society Professorship and the Paul Marks Prize for Cancer Research. \n\n\n\n\n \n \n\n\n\n\n\n\n\nDr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief Scientific Officer and interim Chief Operating Officer at the Dana-Farber Cancer Institute. \nDr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer and have formed the foundation of new translational studies. Dr. Hahn and his colleagues helped demonstrate that activation of the reverse transcriptase telomerase plays an essential role in malignant transformation. This observation provided the means to create novel experimental model systems to identify and characterize the cooperative genetic interactions that lead to malignant transformation. Together with his colleagues at the Broad Institute\, he helped develop genome scale tools and technology to perform somatic cell genetics in human cells. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools\, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn and his collaborators are now engaged in clinical trials testing whether inhibition both of new oncogenes or synthetic lethal partners identified by these approaches will lead to clinical responses. \nDr. Hahn has served as the President of the American Society for Clinical Investigation and has been elected to the Association of American Physicians. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer (2000)\, a Howard Temin Award from the National Cancer Institute (2001)\, the Ho-Am Prize in Medicine (2010)\, the Richard and Hinda Rosenthal Award from AACR (2015) and the Claire and Richard Morse Award (2019).
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-5/
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/bccancerreserachday2020_RearchDay2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200806T080000
DTEND;TZID=America/Vancouver:20200806T170000
DTSTAMP:20260404T214224
CREATED:20200806T153416Z
LAST-MODIFIED:20200806T153416Z
UID:32384-1596700800-1596733200@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:Keynote Speaker Biographies\n\n\n\n\nDr. Bradley E. Bernstein is a Professor of Pathology at Mass General Hospital and Harvard Medical School\, and the Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein’s research focuses on epigenetic gene regulation. His lab studies how gene activity is controlled by noncoding regulatory elements called ‘enhancers’\, and by the way the genes are packaged into chromatin. He is a leader of the NIH’s ENCODE project that is mapping the locations and functions of all noncoding elements in the human genome. His work is notable for the identification of chromatin structures that underlie stem cell pluripotency\, the annotation of enhancers associated with autoimmunity and other diseases\, and the characterization of epigenetic aberrations that turn on oncogenes and drive tumors. \nDr. Bernstein holds the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and is an Elizabeth and Michael Ruane Endowed Scholar in Endocrine Pathology. He received his B.S. from Yale University and his M.D. and Ph.D. from the University of Washington\, before completing a residency in clinical pathology and postdoctoral research at Harvard University. Honors include an Early Career Scientist Award from the Howard Hughes Medical Institute\, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund\, the NIH Director’s Pioneer Award\, an American Cancer Society Professorship and the Paul Marks Prize for Cancer Research. \n\n\n\n\n \n \n\n\n\n\n\n\n\nDr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief Scientific Officer and interim Chief Operating Officer at the Dana-Farber Cancer Institute. \nDr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer and have formed the foundation of new translational studies. Dr. Hahn and his colleagues helped demonstrate that activation of the reverse transcriptase telomerase plays an essential role in malignant transformation. This observation provided the means to create novel experimental model systems to identify and characterize the cooperative genetic interactions that lead to malignant transformation. Together with his colleagues at the Broad Institute\, he helped develop genome scale tools and technology to perform somatic cell genetics in human cells. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools\, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn and his collaborators are now engaged in clinical trials testing whether inhibition both of new oncogenes or synthetic lethal partners identified by these approaches will lead to clinical responses. \nDr. Hahn has served as the President of the American Society for Clinical Investigation and has been elected to the Association of American Physicians. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer (2000)\, a Howard Temin Award from the National Cancer Institute (2001)\, the Ho-Am Prize in Medicine (2010)\, the Richard and Hinda Rosenthal Award from AACR (2015) and the Claire and Richard Morse Award (2019).
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-6/
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/bccancerreserachday2020_RearchDay2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200812T100000
DTEND;TZID=America/Vancouver:20200812T110000
DTSTAMP:20260404T214224
CREATED:20200805T210309Z
LAST-MODIFIED:20200805T210309Z
UID:12246-1597226400-1597230000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Anil Dilawri
DESCRIPTION:This Stem Cells from the Sofa features Anil Dilawri\, a professional presentation trainer and coach\, who will discuss “Effective Distance Communications for Science Professionals”. Distance Communications range from webinars\, to video conferences\, to virtual meetings\, to audio conference calls. \nAnil will provide guidance to attendees to achieve the following:\n– Learn about strategically organizing and structuring your distance communications.\n– Best practices when it comes to maintaining and enhancing your executive presence (physical delivery) during distance communications.\n– How do you have slides that work for you\, not against you?\n– Learn to prepare efficiently and how preparation is different for distance communications environments. \nAnil is the Managing Director of Save it like Sully\, a professional presentation training and coaching company (See http://www.saveitlikesully.com). Anil has worked with many individual leaders and groups from various industries including technology\, retail\, financial services\, healthcare\, education\, industry associations and government. Prior to Save it like Sully Anil held senior positions in research & development\, product marketing\, communications\, and consulting with Hill & Knowlton Strategies\, March Networks\, and Cognos Inc. (now IBM). Anil is a regular guest lecturer at the University of Ottawa\, Queens University\, University of Toronto and Carleton University. In 2013 he was selected as one of the Ottawa Business Journal’s Top Forty Under 40.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-anil-dilawri/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/SCN-Anil-Dilawri.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200812T100000
DTEND;TZID=America/Vancouver:20200812T110000
DTSTAMP:20260404T214224
CREATED:20200805T210309Z
LAST-MODIFIED:20200805T210309Z
UID:26224-1597226400-1597230000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Anil Dilawri
DESCRIPTION:This Stem Cells from the Sofa features Anil Dilawri\, a professional presentation trainer and coach\, who will discuss “Effective Distance Communications for Science Professionals”. Distance Communications range from webinars\, to video conferences\, to virtual meetings\, to audio conference calls. \nAnil will provide guidance to attendees to achieve the following:\n– Learn about strategically organizing and structuring your distance communications.\n– Best practices when it comes to maintaining and enhancing your executive presence (physical delivery) during distance communications.\n– How do you have slides that work for you\, not against you?\n– Learn to prepare efficiently and how preparation is different for distance communications environments. \nAnil is the Managing Director of Save it like Sully\, a professional presentation training and coaching company (See http://www.saveitlikesully.com). Anil has worked with many individual leaders and groups from various industries including technology\, retail\, financial services\, healthcare\, education\, industry associations and government. Prior to Save it like Sully Anil held senior positions in research & development\, product marketing\, communications\, and consulting with Hill & Knowlton Strategies\, March Networks\, and Cognos Inc. (now IBM). Anil is a regular guest lecturer at the University of Ottawa\, Queens University\, University of Toronto and Carleton University. In 2013 he was selected as one of the Ottawa Business Journal’s Top Forty Under 40.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-anil-dilawri-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/SCN-Anil-Dilawri.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200812T100000
DTEND;TZID=America/Vancouver:20200812T110000
DTSTAMP:20260404T214224
CREATED:20200805T210309Z
LAST-MODIFIED:20200805T210309Z
UID:27839-1597226400-1597230000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Anil Dilawri
DESCRIPTION:This Stem Cells from the Sofa features Anil Dilawri\, a professional presentation trainer and coach\, who will discuss “Effective Distance Communications for Science Professionals”. Distance Communications range from webinars\, to video conferences\, to virtual meetings\, to audio conference calls. \nAnil will provide guidance to attendees to achieve the following:\n– Learn about strategically organizing and structuring your distance communications.\n– Best practices when it comes to maintaining and enhancing your executive presence (physical delivery) during distance communications.\n– How do you have slides that work for you\, not against you?\n– Learn to prepare efficiently and how preparation is different for distance communications environments. \nAnil is the Managing Director of Save it like Sully\, a professional presentation training and coaching company (See http://www.saveitlikesully.com). Anil has worked with many individual leaders and groups from various industries including technology\, retail\, financial services\, healthcare\, education\, industry associations and government. Prior to Save it like Sully Anil held senior positions in research & development\, product marketing\, communications\, and consulting with Hill & Knowlton Strategies\, March Networks\, and Cognos Inc. (now IBM). Anil is a regular guest lecturer at the University of Ottawa\, Queens University\, University of Toronto and Carleton University. In 2013 he was selected as one of the Ottawa Business Journal’s Top Forty Under 40.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-anil-dilawri-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/SCN-Anil-Dilawri.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200812T100000
DTEND;TZID=America/Vancouver:20200812T110000
DTSTAMP:20260404T214224
CREATED:20200805T210309Z
LAST-MODIFIED:20200805T210309Z
UID:30922-1597226400-1597230000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Anil Dilawri
DESCRIPTION:This Stem Cells from the Sofa features Anil Dilawri\, a professional presentation trainer and coach\, who will discuss “Effective Distance Communications for Science Professionals”. Distance Communications range from webinars\, to video conferences\, to virtual meetings\, to audio conference calls. \nAnil will provide guidance to attendees to achieve the following:\n– Learn about strategically organizing and structuring your distance communications.\n– Best practices when it comes to maintaining and enhancing your executive presence (physical delivery) during distance communications.\n– How do you have slides that work for you\, not against you?\n– Learn to prepare efficiently and how preparation is different for distance communications environments. \nAnil is the Managing Director of Save it like Sully\, a professional presentation training and coaching company (See http://www.saveitlikesully.com). Anil has worked with many individual leaders and groups from various industries including technology\, retail\, financial services\, healthcare\, education\, industry associations and government. Prior to Save it like Sully Anil held senior positions in research & development\, product marketing\, communications\, and consulting with Hill & Knowlton Strategies\, March Networks\, and Cognos Inc. (now IBM). Anil is a regular guest lecturer at the University of Ottawa\, Queens University\, University of Toronto and Carleton University. In 2013 he was selected as one of the Ottawa Business Journal’s Top Forty Under 40.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-anil-dilawri-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/SCN-Anil-Dilawri.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200812T100000
DTEND;TZID=America/Vancouver:20200812T110000
DTSTAMP:20260404T214224
CREATED:20200805T210309Z
LAST-MODIFIED:20200805T210309Z
UID:32382-1597226400-1597230000@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Anil Dilawri
DESCRIPTION:This Stem Cells from the Sofa features Anil Dilawri\, a professional presentation trainer and coach\, who will discuss “Effective Distance Communications for Science Professionals”. Distance Communications range from webinars\, to video conferences\, to virtual meetings\, to audio conference calls. \nAnil will provide guidance to attendees to achieve the following:\n– Learn about strategically organizing and structuring your distance communications.\n– Best practices when it comes to maintaining and enhancing your executive presence (physical delivery) during distance communications.\n– How do you have slides that work for you\, not against you?\n– Learn to prepare efficiently and how preparation is different for distance communications environments. \nAnil is the Managing Director of Save it like Sully\, a professional presentation training and coaching company (See http://www.saveitlikesully.com). Anil has worked with many individual leaders and groups from various industries including technology\, retail\, financial services\, healthcare\, education\, industry associations and government. Prior to Save it like Sully Anil held senior positions in research & development\, product marketing\, communications\, and consulting with Hill & Knowlton Strategies\, March Networks\, and Cognos Inc. (now IBM). Anil is a regular guest lecturer at the University of Ottawa\, Queens University\, University of Toronto and Carleton University. In 2013 he was selected as one of the Ottawa Business Journal’s Top Forty Under 40.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-anil-dilawri-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/08/SCN-Anil-Dilawri.png
END:VEVENT
END:VCALENDAR